ArticleClinical drug investigation2017

Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS).

Md Motiur Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.